Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Koli Inc
Profile last edited on: 9/21/2015      CAGE: 6GX39      UEI: D9DDUFT7TYW5

Business Identifier: percutaneous solution for gallstone disease
Year Founded
2011
First Award
2012
Latest Award
2024
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

425B Forest Avenue
Palo Alto, CA 94301
   (917) 207-1344
   N/A
   N/A
Location: Single
Congr. District: 18
County: Santa Clara

Public Profile

Koli is a medical device company developing a percutaneous solution for gallstone disease. The new device and procedure will provide a non-surgical alternative for those unable to tolerate surgery, and eliminate complications for those who are waiting for surgery. The solution will make it easier for physicians to treat their patients and reduce total healthcare costs.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
2
Conversion Rate
100.00%
Phase I Dollars
$911,133
Phase II Dollars
$1,877,814
Total Awarded
$2,788,947

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2024 2 NIH $1,497,166
Project Title: Koli: a non-surgical solution for gallstone disease
2017 2 NSF $1,291,781
Project Title: Koli: a Non-Surgical Treatment for Gallstone Disease

Key People / Management

  Christopher Cheng -- CEO

Company News

There are no news available.